Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment

Dec 13, 2019
|
staff reporter

NEW YORK – Researchers from the Institute of Cancer Research, London and the Royal Marsden NHS Foundation Trust have presented data demonstrating that blood-based genotyping assays can accurately detect specific biomarkers and potentially be used to guide targeted treatment of metastatic breast cancer. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

What's Popular?

In Liquid Biopsy

  1. Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

  2. Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

  3. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

  4. Spain's Universal Diagnostics Bets on Cell-Free DNA Methylation for Early-Stage Cancer Detection

    Premium

  5. JP Morgan Downgrades Illumina to Neutral on Grail Deal

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.